Role of iron in anaemic critically ill patients: It's time to investigate!

Critical Care

Volumn 8, Issue 5, 2004, Pages 306-307

  Piagnerelli, Michael ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Anaemia; Erythropoietin; Iron; Red blood cell

Indexed keywords

ERYTHROPOIETIN; IRON;

ANEMIA; ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; PRIORITY JOURNAL;

ANEMIA; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; ERYTHROPOIETIN; HOMEOSTASIS; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; IRON;

EID: 7944232717     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2884     Document Type: Article

References (20)

1. Nguyen Ba V, Peres Bota D, Melot C, Vincent JL: Time course of hemoglobin concentrations in non-bleeding ICU patients. Crit Care Med 2003, 31:406-410.
2. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D: Anemia and blood transfusion in critically ill patients. JAMA 2002, 288: 499-1507.
3. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340:409-417.
4. Piagnerelli M, Boudjeltia KZ, Vanhaeverbeek M, Vincent JL: Red blood cell rheology in sepsis. Intensive Care Med 2003, 29: 1052-1061.
5. Piagnerelli M, Zouaoui Boudjeltia K, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P: Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 2003, 31:1052-1061.
6. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997, 23:159-162.
7. Patruta SI, Horl WH: Iron and infection. Kidney Int Suppl 1999, 69:S125-S130.
8. Rogers JT: Ferritin translation by interleukin-1 and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996, 87:2525-2537.
9. Ludwiczek S, Aigner E, Theurl I, Weiss G: Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003, 101:4148-4154.
10. Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8: 240-246.
11. Rafferty SP, Domachowske JB, Malech HL: Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line. Blood 1996, 88: 070-1078.
12. Darveau M, Denault AY, Blais N, Notebaert E: Bench-to-bedside review: Iron metabolism in critically ill patients. Crit Care 2004, 8:356-362.
13. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999, 27: 2346-2350.
14. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T: Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002, 288:2827-2835.
15. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28:2773-2778.
16. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P: Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002, 346:469-475.
17. Bor-Kucukatay M, Yalcin O, Meiselman HJ, Baskurt OK: Erythropoietin-induced rheological changes of rat erythrocytes. Br J Haematol 2000, 110:82-88.
18. Piron M, Loo M, Gothot A, Tassin F, Fillet G, Beguin Y: Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood 2001, 97:442-448.
19. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102: 83-788.
20. Fillet G, Beguin Y: Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clin Belg 2001, 56:146-154.